PlainRecalls
FDA Drug Moderate Class II Terminated

Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27

Reported: May 13, 2020 Initiated: March 5, 2020 #D-1260-2020

Product Description

Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27

Reason for Recall

CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
600 cartons/2 auto-injector per carton
Distribution
Product was distributed to 1 wholesaler who still had all units within their possession and had not shipped or further distributed any of the product.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Epinephrine Injection USP, 0.3 mg (Auto-Injector), 0.3 mg/ 0.3 mL pre-filled syringe, Rx Only, Manufactured for Teva Pharmaceuticals USA, Inc. North Wales, PA 19454. NDC 0093-5986-27. Recalled by Teva Pharmaceuticals USA. Units affected: 600 cartons/2 auto-injector per carton.
Why was this product recalled?
CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 13, 2020. Severity: Moderate. Recall number: D-1260-2020.